FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q1 2024

Top Holdings175 positions

Checking export access…
Activity:
SPYSPY
PUT

STATE STR SPDR S&P 500 ETF T

11.5M$6B25.6%———
Decreased
—

HESS CORP

6.4M$981.5M4.2%——
2 qtrssince 2023-Q4
Increased
94

PIONEER NATURAL RESOURCES CO

3.5M$924M3.9%——
2 qtrssince 2023-Q4
Increased
66

UNITEDHEALTH GROUP INC

1.7M$841.7M3.6%$451.86+3.57%
5 qtrssince 2023-Q1
Increased
78

IQVIA HLDGS INC

2.8M$717.2M3.0%$163.96+54.24%
22 qtrssince 2018-Q4
Decreased
0

EXELIXIS INC

26.7M$633.1M2.7%$19.36+22.60%
22 qtrssince 2018-Q4
Increased
54

SALESFORCE INC

2M$588M2.5%$173.52+70.54%
18 qtrssince 2019-Q4
Increased
55

ARAMARK

17.8M$579.6M2.5%——
14 qtrssince 2020-Q4
Increased
57

NASDAQ INC

8.4M$532.4M2.3%$57.06+7.04%
3 qtrssince 2023-Q3
Increased
67

MICROSOFT CORP

1.2M$509.7M2.2%$213.45+93.34%
22 qtrssince 2018-Q4
Decreased
0

ALPHABET INC

3.3M$508.2M2.2%$96.46+56.36%
22 qtrssince 2018-Q4
Increased
57

TRANSUNION

6.4M$506.8M2.2%$85.50-7.94%
22 qtrssince 2018-Q4
Decreased
0

NEW YORK TIMES CO MTN BE

11.2M$483.5M2.1%$40.92+2.23%
16 qtrssince 2020-Q2
Increased
63
IBBIBB
PUT

ISHARES TR

3.5M$480.3M2.0%———
New
—

THERMO FISHER SCIENTIFIC INC

797,416$463.5M2.0%$431.27+33.65%
18 qtrssince 2019-Q4
Decreased
0

WABTEC

3M$430.7M1.8%$82.27+74.97%
22 qtrssince 2018-Q4
Decreased
0

CBRE GROUP INC

4.2M$406.9M1.7%$73.86+31.65%
3 qtrssince 2023-Q3
Decreased
0

NATERA INC

3.9M$359.2M1.5%$59.93+52.62%
12 qtrssince 2021-Q2
Increased
55

INTUIT

537,078$349.1M1.5%$378.77+67.36%
6 qtrssince 2022-Q4
Increased
49

S&P GLOBAL INC

793,844$337.7M1.4%$298.42+32.22%
8 qtrssince 2022-Q2
Decreased
0
$23.6B
AUM
175
Positions
Q1 2024
Filing
HI score · 1.0/5
Quarterly 13F Value Change
-7%Q4'22$16.9B+8%Q1'23$18.3B+9%Q2'23$19.9B+8%Q3'23$21.4B+2%Q4'23$21.9B+8%Q1'24$23.6B
Activity profile
$ moved · Q1'24
New22%Increased37%Decreased23%Exited18%
Composition
Equity vs derivatives
Equity72%Puts28%Calls0%
Holding period
Avg 2.1 years
<1Q18%1-4Q20%1-2Y11%2Y+51%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $23.6B across 175 positions as of Q1 2024. Top holdings: SPY puts (25.6%), HES (4.2%), PXD (3.9%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.

Q1 2024 Summary

Active quarter - 41 new positions, 26 exits, 38 increased. Top move: HES (INCREASED, conviction 94). Portfolio: $23.6B across 175 positions.

Top holdings by portfolio weight

Total AUM$17B
HES4.16%
PXD3.92%
UNH3.57%
IQV3.04%
EXEL2.69%
CRM2.49%
ARMK2.46%
NDAQ2.26%
MSFT2.16%
GOOG2.16%
Other2.15%

Portfolio allocation by GICS sector

Sectors11
Healthcare35.67%
Unknown15.94%
Technology13.91%
Financial Services12.17%
Industrials8.04%
Communication Services5.96%
Real Estate4.34%
Consumer Cyclical1.79%
Basic Materials1.63%
Consumer Defensive0.41%
Other0.13%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L51
Conviction44
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BBIOBBIOBRIDGEBIO PHARMA INC COM
Q4 2024 → Q2 2026+9M shares+$755.7M
7Q
CRNXCRNX<![CDATA[CRINETICS PHARMACEUTICALS INC]]>
Q4 2024 → Q2 2026+7.8M shares+$277M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 → Q2 2026+6.8M shares+$69.5M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used